Sequence data will become increasingly important as SARS-CoV-2 vaccines and antivirals become available. ECDC's technical guidance provides guidelines to laboratories and relevant stakeholders, addressing the most used sequencing technologies and their applications, and proposes a central standardisation process to analyse and report the findings of SARS-CoV-2 genetic characterisations.
Risk related to spread of new SARS-CoV-2 variants of concern
ECDC presents the latest available information on the recent emergence of two variants of potential concern discovered in the United Kingdom and another variant identified in South Africa.
Data on hospital and ICU admission rates and current occupancy for COVID-19
Data-
Data
Data on the 14-day age-specific notification rate of new COVID-19 cases
Data-
Data
Data for the maps in support of the Council Recommendation on a coordinated approach to the restriction of free movement in response to the COVID-19 pandemic in the EU/EEA